SELLAS Life Sciences (SLS) Return on Equity (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Return on Equity for 9 consecutive years, with 3.43% as the latest value for Q3 2024.
- Quarterly Return on Equity rose 7302.0% to 3.43% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 3.43% through Sep 2024, up 7302.0% year-over-year, with the annual reading at 23.9% for FY2023, 2718.0% up from the prior year.
- Return on Equity for Q3 2024 was 3.43% at SELLAS Life Sciences, up from 5.47% in the prior quarter.
- The five-year high for Return on Equity was 6.36% in Q4 2023, with the low at 76.45% in Q3 2023.
- Average Return on Equity over 5 years is 7.98%, with a median of 2.79% recorded in 2022.
- The sharpest move saw Return on Equity tumbled -7366bps in 2023, then surged 7302bps in 2024.
- Over 5 years, Return on Equity stood at 0.95% in 2020, then dropped by -14bps to 1.08% in 2021, then plummeted by -346bps to 4.81% in 2022, then surged by 232bps to 6.36% in 2023, then tumbled by -154bps to 3.43% in 2024.
- According to Business Quant data, Return on Equity over the past three periods came in at 3.43%, 5.47%, and 41.93% for Q3 2024, Q2 2024, and Q1 2024 respectively.